FDA Inspection
CSPC Ouyi Pharmaceutical Co., Ltd.CSPC Ouyi Pharmaceutical Co., Ltd. – FDA Inspection, Aug 2, 2017
Record Details
This FDA Inspection record concerns CSPC Ouyi Pharmaceutical Co., Ltd., with an inspection on August 2, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 8df18b47-2fdb-4f4f-b2c7-9035e7a4f18d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1021148
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of CSPC Ouyi Pharmaceutical Co., Ltd.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| September 5, 2024 | Not classified | Office of Inspections and Investigations | |
| May 17, 2019 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| June 15, 2018 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| October 20, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 25, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for CSPC Ouyi Pharmaceutical Co., Ltd.
- FDA Inspection 1239361 - 2024-09-05
- FDA Inspection 1091103 - 2019-05-17
- FDA Inspection 1058543 - 2018-06-15
- FDA Inspection 1036247 - 2017-10-20
- FDA Inspection 945964 - 2015-09-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.